Literature DB >> 31684890

Co-existence of virulence factors and antibiotic resistance in new Klebsiella pneumoniae clones emerging in south of Italy.

Teresa Fasciana1, Bernardina Gentile2, Maria Aquilina3, Andrea Ciammaruconi2, Chiara Mascarella3, Anna Anselmo2, Antonella Fortunato2, Silvia Fillo2, Giancarlo Petralito2, Florigio Lista2, Anna Giammanco3.   

Abstract

BACKGROUND: Endemic presence of Klebsiella pneumoniae resistant to carbapenem in Italy has been due principally to the clonal expansion of CC258 isolates; however, recent studies suggest an ongoing epidemiological change in this geographical area.
METHODS: 50 K. pneumoniae strains, 25 carbapenem-resistant (CR-Kp) and 25 susceptible (CS-Kp), collected from march 2014 to march 2016 at the Laboratory of Bacteriology of the Paolo Giaccone Polyclinic University hospital of Palermo, Italy, were characterized for antibiotic susceptibility and fully sequenced by next generation sequencing (NGS) for the in silico analysis of resistome, virulome, multi-locus sequence typing (MLST) and core single nucleotide polymorphism (SNP) genotypes
RESULTS: MLST in silico analysis of CR-Kp showed that 52% of isolates belonged to CC258, followed by ST395 (12%), ST307 (12%), ST392 (8%), ST348 (8%), ST405 (4%) and ST101 (4%). In the CS-Kp group, the most represented isolate was ST405 (20%), followed by ST392 and ST15 (12%), ST395, ST307 and ST1727 (8%). The in silico β-lactamase analysis of the CR-Kp group showed that the most detected gene was blaSHV (100%), followed by blaTEM (92%), blaKPC (88%), blaOXA (88%) and blaCTX-M (32%). The virulome analysis detected mrk operon in all studied isolates, and wzi-2 was found in three CR-Kp isolates (12%). Furthermore, the distribution of virulence genes encoding for the yersiniabactin system, its receptor fyuA and the aerobactin system did not show significant distribution differences between CR-Kp and CS-Kp, whereas the Klebsiella ferrous iron uptake system (kfuA, kfuB and kfuC genes), the two-component system kvgAS and the microcin E495 were significantly (p < 0.05) prevalent in the CS-Kp group compared to the CR-Kp group. Core SNP genotyping, correlating with the MLST data, allowed greater strain tracking and discrimination than MLST analysis.
CONCLUSIONS: Our data support the idea that an epidemiological change is ongoing in the Palermo area (Sicily, Italy). In addition, our analysis revealed the co-existence of antibiotic resistance and virulence factors in CR-Kp isolates; this characteristic should be considered for future genomic surveillance studies.

Entities:  

Keywords:  Carbapenem-resistant Klebsiella pneumoniae; Virulence factors

Mesh:

Substances:

Year:  2019        PMID: 31684890      PMCID: PMC6829812          DOI: 10.1186/s12879-019-4565-3

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


Background

The World Health Organization (WHO), the US Centers for Disease Control and Prevention (CDC) and the UK Department of Health have indicated Klebsiella pneumoniae as one of the multi drug resistant (MDR) microorganisms constituting an immediate threat for human health [1-3]. K. pneumoniae, an opportunistic pathogen, has emerged not only thanks to its ability to accumulate multiclass antibiotic resistance determinants over time [1] but also, as widely reported, to its adeptness in causing severe community- and hospital-associated infections [4-6]. K. pneumoniae “permeability” to mobile genetic elements is a key factor for its dissemination not only with respect to the possibility of becoming resistant to antibiotics, but also of evolving towards more virulent phenotypes thanks to genes that may provide a survival benefit to microorganisms [7, 8]. However, in K. pneumoniae the relation between resistance and virulence is a complex issue since a systematic understanding of its population structure is still lacking [4, 9]. This makes it difficult to perceive the emergence of new clones, what instead could be an advantageous approach to develop epidemiological surveillance programs and avoid outbreaks, particularly of strains which have become resistant to carbapenem (carbapenem-resistant K. pneumoniae, CR-Kp) [9-11]. The existing body of research on carbapenem-resistance mechanisms suggests that the production of K. pneumoniae carbapenemase (KPC) encoded by the plasmidic gene blaKPC is the most common one and its rapid dissemination has typically been caused by the clonal expansion of clonal complex (CC) 258 strains, including ST258 and ST512 [12-16]. In Italy, the first KPC-positive K. pneumoniae, belonging to ST258, was isolated in Florence in 2008 [17]. Since then, the diffusion of these strains has been evident. In fact, the last European Antimicrobial Resistance Surveillance Network report has confirmed an average prevalence of CR-Kp of up to 33.9%, percentages that make Italy an endemic country for this microorganism [18, 19]. To date, although some research has been carried out on the diffusion and genetic characteristics of KPC-positive K. pneumoniae in our region (Sicily, Italy), no single study exists which has comprehensively described these strains considering all of the Hospital’s Departments for a period longer than 1 year [20-24]. In this study, we fully sequenced 50 K. pneumoniae strains, both carbapenem resistant and -susceptible, collected from March 2014 to March 2016 at the Laboratory of Bacteriology of the Department of Sciences for Health Promotion and Mother-Child Care “G. D’Alessandro” (Paolo Giaccone Polyclinic University Hospital, University of Palermo, Italy). The primary aim of this study was to take a current snapshot of the distribution of K. pneumoniae in our geographic area by: 1) characterizing the virulome and resistome of CR-Kp clones; 2) assessing the extent to which virulence determinants were carried by CR-Kp and CS-Kp (carbapenem susceptible K. pneumoniae); 3) investigating the phylogenetic correlations among samples by Multilocus sequence typing (MLST) in silico and the analysis of core single nucleotide polymorphisms (SNPs).

Methods

Bacterial strains and antimicrobial susceptibility testing

Species and antimicrobial susceptibility were determined using the Becton- Dickinson Phoenix™ automated system (Becton Dickinson, Sparks, MD, USA). Resistance to carbapenem was established by interpreting the results of the antimicrobial susceptibility test on the basis of the breakpoint criteria of the European Committee on Antimicrobial Susceptibility Testing [25]. On the base of carbapenem susceptibility the 50 strains were divided in 25 isolates resistant (CR-Kp) and 25 sensitive (CS-Kp). Table 1 shows the entire clinical sample and the departments of isolation.
Table 1

K. pneumoniae CR and CS isolates, department of isolations, host disease, host age and clinical sample

CR-Kp IDDepartmenthost diseasehost ageSampleCS-Kp IDDepartmenthost diseasehost ageSample
1 RGeneral surgeries emergenciessepsi70Blood PVC1 SEndocrinology and Metabolic diseasesICU75Urine
2 RAnaesthesia and resuscitationsepsi46Blood CVC2 SSurgical OncologyICU81Urine
3 RAnaesthesia and resuscitationsepsi59Blood PVC3 SNephrology and HypertensionICU70Urine
4 RAnaesthesia and resuscitationpneumoniae60Bronchoalveolar lavage4 SClinical Respiratory MedicineICU64Urine
5 RGeneral surgeries emergenciessepsi36Intra-abdominal fluid5 SGeneral and Thoracic SurgeryICU52Wound swab
6 RInternal Medicine Cardioangiologysepsi36Blood PVC6 SGeriatric medicineinfected wound21Urine
7 RCardiac surgerysepsi53Blood CVC7 SGeriatric medicineICU82Ulcer swab
8 RClinical Respiratory MedicineICU77Urine8 SPlastic surgeryinfected wound82Tissue
9 RInternal MedicineICU49Urine9 SClinical Respiratory Medicineinfected wound74Urine
10 RClinical Respiratory MedicineICU79Urine10 SInternal Medicine CardioangiologyICU76Sputum
11 RGeriatric medicineICU90Urine11 SInfectious diseasepneumoniae77Sputum
12 REndocrinology and Metabolic diseasesICU84Urine12 SClinical Respiratory Medicinepneumoniae22Bronchoalveolar lavage
13 RAnaesthesia and resuscitationsepsi70Blood PVC13 SNICUpneumoniae81Endotracheal tube
14 RInternal Medicine Cardioangiologysepsi54CVC14 SHaematology and Bone Marrow Transplantationpneumoniae15 daysSputum
15 RCardiac surgerypneumoniae72Bronchoalveolar lavage15 SRheumatologypneumoniae83Urine
16 RAnaesthesia and resuscitationICU60Urine16 SInternal MedicineICU73Sputum
17 RInternal Medicine Cardioangiologyinfected wound38Ulcer swab17 SGeriatric medicinepneumoniae76Urine
18 RInternal Medicine Cardioangiologypneumoniae77Sputum18 SRheumatologyICU36Urine
19RCardiac surgeryinfected wound71Wound swab19 SClinical Respiratory MedicineICU91Sputum
20 RClinical Respiratory MedicineICU80Urine20 SGeneral surgeries emergenciespneumoniae63Liquor
21 RGeneral surgeries emergenciesbile infections65Bile21 SInternal Medicine CardioangiologyMeningitidis92Urine
22 RAnaesthesia and resuscitationsepsi70Blood CVC22 SAnaesthesia and resuscitationICU82Urine
23 RCardiac surgerypneumoniae62Sputum23 SHaematology and Bone Marrow TransplantationICU70Cutaneous swab
24RGeneral surgeries emergenciessepsi72Intra-abdominal fluid24 STourism and Migrationinfected wound81Urine
25 RGeneral surgeries emergenciessepsi54Abscess fluid25 SInternal Medicine CardioangiologyICU71Urine

CVC: central venous catheter, ICU: intensive care unit, NICU: neonatal intensive care unit, PVC: Peripheral venous catheter

K. pneumoniae CR and CS isolates, department of isolations, host disease, host age and clinical sample CVC: central venous catheter, ICU: intensive care unit, NICU: neonatal intensive care unit, PVC: Peripheral venous catheter

DNA isolation

The template DNA was prepared from bacterial colonies grown for 18 h on Blood Agar plates. Colonies were picked and suspended in 500 μl of ultra-pure DNase-free water. The suspension was harvested at 14000 rpm for 10 min. The supernatants were discarded while DNA from the pellets were extracted using the QIAmp® DNA Mini kit Qiagen (QIAGEN; Hilden, Germany), the quantity and purity of the DNA were determined using NanoDrop 8000 spectrophotometer (Thermo Fisher Scientific, Waltham).

Whole-genome sequencing

Isolate’s genomes were fully sequenced at the Scientific Department, Army Medical Center, Military Polyclinic of Rome (Italy) using the next-generation sequencing on the Illumina MiSeq platform (San Diego, CA, USA) as recommended by the manufacturer. The library sizes had peaks centered from 900 to 1000 bp. The reads were de novo assembled into contigs using AByss, version 1.5.2 (k parameter = 63) [22]. Contigs longer than 500 bp were selected using an ad hoc script and kept for further analysis. The final assembly ranged from 44 to 414 (median: 143) contigs per sample (N50: 335,064–64,441; median: 111,289). Contigs were merged through the Minimus2 software (Sommer et al., 2007) and resulting DNA sequences were analysed for similarity using the database sequences by the Standard Nucleotide BLAST program (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Illumina-generated sequence data for the whole data set of this study have been deposited at NCBI (BioProject id: PRJNA515715 and accession number SUB5047324).

Analysis of virulome and resistome

Virulome of all K. pneumoniae sample was analysed using the VirulenceFinder-1.4 tool and the Pasteur K. pneumoniae database. The resistome of carbapenem-resistant K. pneumoniae was analysed using the ResFinder-2.1 software (default identity thresholds [ID] 98%) which was provided by the Center for Genomic Epidemiology (http://www.genomicepidemiology.org) and the resources of the Pasteur MLST K. pneumoniae database.

Multilocus sequence typing (MLST) in silico

he in silico MLST analysis was made by comparing the whole-genome sequences against the K. pneumoniae alleles profiles available at http://www.pasteur.fr/mlst (Genotyping of Pathogens and Public Health, Institute Pasteur, Paris, France).

Core single-nucleotide polymorphisms (SNPs)

Phylogenetic analysis based on genome-wide single nucleotide polymorphisms (SNPs) were conducted detecting SNPs through the kSNP v2.1.2 program (k-mer = 21), which defines a SNP locus as an oligo of length k surrounding a central SNP allele [26]. Maximum likelihood tree based on the 57,766 core SNPs identified by kSNP program was visualised using the Dendroscope v3.2.10 software [27]. Strain 8S, K. pseudopneumoniae, was used as outgroup to root the tree.

Statistical analysis

Data were expressed as absolute numbers or percentages. The Chi-squared test was used to compare proportions (as appropriate). Values of p < 0.05 were considered statistically significant. The statistical analysis were performed with MedCalc Statistical software version 16.8 (MedCalc Software bvba, Ostend, Belgium; https://www.medcalc.org; 2016).

Results

CR-Kp were mainly isolated from blood and urinary samples (28% for both) (Fig. 1), while the ward from which CR-Kp was primarily isolated was the Anaesthesia and Resuscitation Department (24%) (Table 1). Regarding CS-Kp, urines were the major isolation sample (52%) (Fig. 1), while the ward from which CS-Kp was primarily isolated was the Respiratory Department (52%) (Table 1).
Fig. 1

Samples from where isolated the strains

Samples from where isolated the strains

Antibiotic resistance

The percentages of antibiotic resistance among K. pneumoniae carbapenem-resistant and carbapenem-susceptible strains are reported in Table 2. As shown, the CR-Kp group displayed a higher percentage of resistance for all tested antibiotics compared to the susceptible group. Statistical significance was calculated where applicable. In particular, 20% of CR-Kp and 4% of CS-Kp were colistin-resistant. Complete antibiotic resistance profile of CR-Kp are shown in Additional file 1.
Table 2

Percentage of antibiotic resistance in carbapenem resistant and susceptible K. pneumoniae

ClassAntibioticsK. pneumoniae CR %K. pneumoniae CS %P value
AminoglicosydesGentamycin64480.022
CarbapenemsImipenem1000NA
Meropenem1000NA
Ertapenem1000NA
MonobactamsAztreonam10060NA
FluoroquinolonesCiprofloxacin10064NA

Sulfonamides-

Trimethoprim

Trimethoprim-sulfamethoxazole76600.015
PenicillinAmoxicillin/ clavulanic acid10056NA
Piperacillin/tazobactam10044NA
CephalosporinCefotaxime10060NA
Cefuroxime10060NA
Cefepime88560
Ceftazidime10060NA
Fosfomycin c/G6P36160.001
TetracyclinTigecyclin840.233
Colistin2040

NA: chi-squared test not applicable

Percentage of antibiotic resistance in carbapenem resistant and susceptible K. pneumoniae Sulfonamides- Trimethoprim NA: chi-squared test not applicable

MLST analysis and Core single-nucleotide polymorphisms (SNPs) phylogenetic analysis

MLST in silico analysis of CR-Kp revealed that 52% belonged to CC258. In particular, 5 strains were ST258 (20%) and 8 were ST512 (32%). The remaining 12 strains were distributed as follows: 3 were ST395 (12%), 3 were ST307 (12%), 2 were ST392 (8%), 2 were ST348 (8%), 1 was ST405 (4%) and 1 was ST101 (4%). Among CS-Kp’s we detected 14 different STs. ST405 was the most represented (5 strains, 20%), followed by ST392 and ST15 (3 strains, 12%), ST395, ST307 and ST1727 (2 strains, 8%), and one strain each for all other STs. Figure 2 shows ST distribution across the entire sample.
Fig. 2

Percentage of ST found

Percentage of ST found The core-SNP phylogenetic analysis showed that strains belonging to the same ST clustered in the same groups, without regard to CR susceptibility or resistance (see Additional file 3). Moreover, the SNP analysis allows distinguishing each different strain.

Virulome: CR-Kp group versus CS-Kp group

Virulence factors distribution in CR-Kp and CS-Kp is detailed in Table 3. The mrk operon, which encodes type 3 fimbriae, was detected in all isolates. The wzi gene, involved in the capsule attachment to the host cell surface and used for the prediction of capsular (K) antigen type, was found in all CR-Kp isolates (100%), in particular, 3 strains carried the wzi-2 allele (see Additional file 4). Regarding the iron acquisition systems, the distribution of genes encoding for the yersiniabactin system (ybt), its receptor fyuA and the aerobactin system did not show significant differences between CR-Kp and CS-Kp (Table 3). Klebsiella ferrous iron uptake system (kfuA, kfuB and kfuC genes), the two-component system kvgAS and the microcin E495 were significantly (p < 0.05) prevalent in the CS-Kp group (28%) compared to the CR-Kp one (4%) (Table 3).
Table 3

Distribution of virulence factors in carbapenem resistant and susceptible K. pneumoniae strains

Virulence factorsLocus-GenesK. pneumoniae CRn (%)K. pneumoniae CSn (%)P value
Type 3 fimbriesmrk operon25 (100%)25 (100%)1.000
Capsule wzi 25 (100%)23 (92%)0.552
Iron acquisition systemsybt operon10 (40%)15 (60%)0.089

Aerobactin iron acquisition siderophore

(iucABCD)

3 (12%)3 (12%)1.000

Klebsiella

Ferric ionic-uptake system

(kfuABC)

1 (4%)7 (28%)0.020
Two-component systemkvgAS1 (4%)7 (28%)0.020
BacteriocinMicrocin E4921 (4%)7 (28%)0.020
Distribution of virulence factors in carbapenem resistant and susceptible K. pneumoniae strains Aerobactin iron acquisition siderophore (iucABCD) Klebsiella Ferric ionic-uptake system (kfuABC) Table 4 displays the comparative analysis of virulence determinants between CR-Kp and CS-Kp belonging to the same ST. All strains belonging to ST405, regardless of their resistance profile, had the same determinants (mrk, wzi-143, ybt, microcin E495 and kvgAS. Regarding the strains belonging to ST307, both CR-Kp and CS-Kp strains had the mrk operon, wzi-173 and ybt operon, with the exception of the 5R isolate, lacking ybt genes (Table 4).
Table 4

Distribution of virulence determinants in STs clone of K. pneumoniae CR and CS

STsCR-KpCS-Kp
ST395mrk, wzi-2, ybt, yuc,mrk, wzi-2, ybt, yuc
ST307mrk, wzi-173 ybt 1mrk, wzi-173, ybt
ST392mrk, wzi-187mrk, wzi-187
ST405mrk, wzi-143, ybt, kvgAS, E495mrk, wzi-143, ybt, kvgAS, E495

1missing in one of the three CR isolates

Distribution of virulence determinants in STs clone of K. pneumoniae CR and CS 1missing in one of the three CR isolates

Virulome subanalysis by STs across the CR-Kp group

CR-Kp isolates belonging to ST512, ST258 did not carry virulence determinants other than mrk and wzi (Table 4). The three strains belonging to ST395 carried four virulence determinants: mrk, fyuA/irp2, iucABCD and wzi type 2. wzi gene type 27 was found in the two ST392 isolates together with the mrk operon. Strains belonging to ST348 carried the mrk operon, ybt operon and wzi-94 gene, whereas the ST101 strain exhibited mrk, ybt operon, wzi type 17 and the kfuABC system. The ST405 isolate was the only one that carried the kvgAS operon and the microcin E495, together with the mrk operon, ybt operon and the wzi-143.

Resistome analysis across the CR-Kp group

The in silico β-lactamase characterisation of CR-Kp isolates showed that the most frequent carbapenemase-producing gene was blaSHV (100%). In particular, SHV variant 182 was detected in 16 out of 25 isolates (64%), while variant 28 in four strains (16%), three ST307 and the only ST101 isolate. blaKPC was identified in 88% of isolates and the most common variant was blaKPC-3 (90.9%). blaTEM was found in 23 isolates (92%), all of which were variant 1 and blaCTX-M (variant 15) was found in 8 isolates (32%). blaOXA was found in 22 isolates (88%), 14 of these were variant 9 (63.6%), 5 were variant 1 (22.72%) and 3 isolates (13.63%) presented both variants, blaOXA-1 and blaOXA-9. Five isolates, one belonging to ST395, two to ST307, one to ST101 and one to ST405 owned all the five carbapenemase-producing genes investigated (Table 5). Complete data from the in silico analysis (e.g. encoding efflux pumps, heavy metal resistance system, genes involved in aminoglycoside and fluoroquinolone resistance) are shown in Additional file 2.
Table 5

K. pneumoniae CR profile: colistin susceptibility, carbapenemase, ESBL and beta-lactamases genes

STsIDCS (mg/L)bla KPCbla SHVbla CTX-Mbla TEMbla OXA
ST5126 R<=1318219
7 R<=1318219
8 R<=13182
11 R<=1318219
16 R<=1318219
19 R> 431821
22 R<=1318219
25 R<=1318219
ST25812 R<=1318219
18 R<=1318219
21 R<=1318219
23 R> 4318219
24 R<=1318219
ST3952 R<=131821
4 R<=131821511
10 R<=131821
ST3075 R<=19281519
13 R<=13281511/9
20 R> 4 R22811/9
ST3921 R<=13671519
3 R<=1671511
ST 34815 R> 4 R811511
17 R<=1811511
ST 1019 R<=132819
ST 40514 R> 4 R3761511/9
K. pneumoniae CR profile: colistin susceptibility, carbapenemase, ESBL and beta-lactamases genes

Discussion

The epidemiology of CR-Kp in our geographic area (Palermo, Italy) has already been characterized in the late 2008 at the emergence of CR-Kp ST258 clones [20]. However, several reports have suggested an ongoing epidemiological change in the last years. In fact, whereas CC258 (ST258 and ST512) is still prevalent, several other STs are emerging and circulating [23, 24, 28]. This study set out with the aim of assessing the current dissemination and genetic characteristics of K. pneumoniae in Palermo. Even though a larger sample may have allowed to gain more representative data, our preliminary data reveal a complex situation characterized by: 1) high genome “plasticity” of both CR-Kp and CS-Kp, due to the presence of several virulence and resistance determinants carried by mobile genetic elements; 2) a CR-Kp group showing an important genetic diversity of lineages, with 8 different STs identified; 3) an overlapping of multi-drug resistance and hyper virulence traits in the CR-Kp group. Regarding STs, our comprehensive analysis indicates that, although ST258 and ST512 remain the most representative ones, other STs (e.g. ST307, ST395, ST392, ST348, ST405 and ST101) have been detected in our area. These results are consistent with the surveillance data from other authors [20–24, 28]. Moreover, our findings on β-lactamase characterisation showed that the blaSHV gene was the most commonly found in our sample, followed by blaTEM and blaKPC, deviating from other studies [11, 29, 30], while respect to the KPC-type enzyme our results are in line with those of other studies - as the most commonly encountered is blaKPC-3 [21, 23, 31–33]. Regarding STs, the most represented across the CR-Kp group were ST512 and ST258. These isolates did not carry any distinguishing virulence determinant (except for the mrk operon and wzi gene, which were present in all the samples), suggesting that the success of these clones may only depend on the acquisition of the blaKPC gene [9, 15, 34]. Among the ST512 isolates, we found the 19R strain profile to be particularly interesting. This colistin-resistant strain was the only one in its ST group that showed both the yersiniabactin system and its receptor, which has been detected in several K. pneumoniae MDR clones; despite of this, the clinical effect of the yersiniabactin system on CR-Kp infections has not been clearly determined [4, 35, 36]. Our data also match those of reports suggesting the recent spread of the well-known clone ST307. In fact, in 2014, a CR-Kp ST307 clone carrying the blaKPC-3, coproducing the blaCTX-M-15, has been isolated in three Palermo’s Hospitals [23]. The virulome analysis of our ST307 strains has revealed, that 5R isolate was the only one missing the yersiniabactin locus in its ST group. Furthermore, 13R and 5R isolates, two of the three strains belonging to ST307, showed the co-presence of all five carbapenem resistance genes analysed. The co-presence of the detected virulence factors together with the MDR phenotype may explain the diffusion of this clone and the severity of its infections, which have been reported as characterised by higher mortality rates (over 50%) compared to other clones [37, 38]. Moreover, leaving aside specific considerations about the clone ST307, the co-presence of five carbapenem resistance genes that we detected in five strains of our sample (20%) is in line with that of a study by Ferreira et al., which has recently reported that 72% of the K. pneumoniae isolated from a Brazilian Intensive care Unite co-produced blaKPC, blaOXA, blaTEM, blaSHV, and blaCTX-M [39]. Another emerging clone, already isolated by other authors in Palermo and also detected in our CR-Kp sample, was the ST395 [40]. Strains belonging to this clone presented the wzi2 allele, which encodes the type K2 capsular antigen that represents one of the most virulent serotypes, thus defined “more virulent” [41, 42]. CR-Kp ST395 strains also carried the yersiniabactin system and its receptor and were the only resistant isolates to possess the aerobactin system (iucABCD). Two aspects of these strains should be addressed here: i) 4R isolate showed the co-presence of five carbapenem resistance genes; ii) to the best of our knowledge, this is the first time that a CR-Kp ST395 clone is reported as carrying a type 2 capsule. This finding was unexpected and seems to be in contrast with the concept that MDR and hyper virulent clonal complexes do not normally overlap [42]. Moreover, our data confirm the spreading of the ST392 clone. A recently published study by Di Mento and colleagues has reported, for the first time, the isolation of a K. pneumoniae strain ST392 blaKPC-3 carrying the blaCTX-M-15, blaSHV-11 and blaTEM-1 genes from a patient in Palermo who had undergone kidney-pancreas transplantation [43]. In our CR-Kp ST392 sample, the 1R strain which was isolated from blood at the General and Emergency Surgery Department in 2015, showed the co-existence of blaKPC-3, blaSHV-67, blaCTX-M-15, blaTEM-1 and blaOXA-9. This result is interesting as the only other KPC-producing K. pneumoniae ST392 ever reported was isolated in China but with a different isoform, KPC-2 [44]. However, it is important to underline that the other ST392 strain (3R) in our CR-Kp sample did not carry the blaKPC gene, suggesting that the ST392 KPC-3 clone may have acquired the resistance gene through horizontal transmission, as described by other authors [43]. This study also revealed two MDR CR-Kps belonging to ST348 and carrying the blaCTX-M-15, blaSHV-81, blaTEM-1 and blaOXA-1 genes. Strains belonged to ST348, but harboured the blaKPC-3, which had been previously reported as responsible of several epidemic events in Portugal [45]. Considering that one of our isolates was colistin-resistant and the ease with which K. pneumoniae acquires the blaKPC gene, we can consider the MDR CR-Kp ST348 strains as possibly emerging high-risk clones. Three other important data that emerge from our results and complete the description of the CR-Kp epidemiological scene in Palermo are: firstly, the circulation of strains belonging to ST101. This clone was previously recognized worldwide as a high risk carbapenem-producing clone [30] and has already been identified in Palermo and in the North of Italy [46-48]. Our ST101 strain (9R) carried the blaKPC-3, blaSHV-28, blaTEM-1 and blaOXA-9 genes and the Klebsiella ferrous uptake system, which is typically found in K. pneumoniae hypervirulent strains [49, 50]; secondly, the characteristic of the strain belonging to ST405, which carried the blaKPC-3, blaCTX-15, blaSHV-76, blaTEM-1 and blaOXA-1/9 genes, the aac6-Ib-cr and qnrB and was resistant to colistin. Strains from ST405 have similarly caused an outbreak in a Spanish Hospital neonatal unit [50] and have already been isolated in Palermo [24]. It is important to underline that the genes involved in microcin production and kvgA/S system were detected in all isolates belonging to ST405, both resistant and susceptible to carbapenem, possibly indicating a stable and characteristic genetic pattern for these clones; lastly to the best of our knowledge this is the first study to report in Italy the isolation of five CR-Kp isolates belonging to different STs showing the co-presence of five carbapenem resistance genes.

Conclusions

These results are significant in at least two major respects. Overall, this study strengthens the idea that the epidemiological frame in the Palermo area (Sicily, Italy) is shifting and new MDR clones are emerging. However, our analysis, which included the comparison of the virulence degree of CS-Kp and CR-Kp isolates, has unexpectedly revealed that the latter are acquiring highly-virulent determinants and the co-presence of more resistance genes. Undoubtedly, since co-existence of antibiotic resistance and virulence factors may lead to life-threatening untreatable and invasive K. pneumoniae infections, this is an important issue to take into consideration for future genomic surveillance studies. Additional file 1. K. pneumoniae CR antibiotic resistance profile. Results of antibiotic resistance assay of K. pneumoniae CR. Additional file 2. K. pneumoniae CR in silico analysis of resistome and virulome. Results of in silico analysis of sequences encoding for efflux pumps, heavy metal resistance system, and genes involved to aminoglycoside and fluoroquinolone resistance. Additional file 3. wzi analysis of CR-K and CS-K. Table of contig and allele of wzi gene in K. pneumoniae CR and CS. Additional file 4. SNP phylogenetic tree. Core Single-Nucleotide Polymorphisms dendrogram.
  45 in total

1.  Genomic epidemiology of Klebsiella pneumoniae in Italy and novel insights into the origin and global evolution of its resistance to carbapenem antibiotics.

Authors:  Stefano Gaiarsa; Francesco Comandatore; Paolo Gaibani; Marta Corbella; Claudia Dalla Valle; Sara Epis; Erika Scaltriti; Edoardo Carretto; Claudio Farina; Maria Labonia; Maria Paola Landini; Stefano Pongolini; Vittorio Sambri; Claudio Bandi; Piero Marone; Davide Sassera
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Characterization of an outbreak due to CTX-M-15-producing Klebsiella pneumoniae lacking the blaOXA-48 gene belonging to clone ST405 in a neonatal unit in southern Spain.

Authors:  Jesús Machuca; Lorena López-Cerero; Felipe Fernández-Cuenca; Irene Gracia-Ahufinger; Guillermo Ruiz-Carrascoso; Fernando Rodríguez-López; Álvaro Pascual
Journal:  J Antimicrob Chemother       Date:  2016-04-26       Impact factor: 5.790

3.  Emergence of a Klebsiella pneumoniae ST392 clone harbouring KPC-3 in an Italian transplantation hospital.

Authors:  G Di Mento; N Cuscino; C Carcione; F Cardinale; P G Conaldi; B Douradinha
Journal:  J Hosp Infect       Date:  2017-12-05       Impact factor: 3.926

Review 4.  Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance.

Authors:  Johann D D Pitout; Patrice Nordmann; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

5.  Genomic heterogeneity in Klebsiella pneumoniae strains is associated with primary pyogenic liver abscess and metastatic infection.

Authors:  Li-Chen Ma; Chi-Tai Fang; Cha-Ze Lee; Chia-Tung Shun; Jin-Town Wang
Journal:  J Infect Dis       Date:  2005-05-25       Impact factor: 5.226

Review 6.  Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.

Authors:  L Silvia Munoz-Price; Laurent Poirel; Robert A Bonomo; Mitchell J Schwaber; George L Daikos; Martin Cormican; Giuseppe Cornaglia; Javier Garau; Marek Gniadkowski; Mary K Hayden; Karthikeyan Kumarasamy; David M Livermore; Juan J Maya; Patrice Nordmann; Jean B Patel; David L Paterson; Johann Pitout; Maria Virginia Villegas; Hui Wang; Neil Woodford; John P Quinn
Journal:  Lancet Infect Dis       Date:  2013-09       Impact factor: 25.071

7.  An Update of the Evolving Epidemic of blaKPC Carrying Klebsiella pneumoniae in Sicily, Italy, 2014: Emergence of Multiple Non-ST258 Clones.

Authors:  Celestino Bonura; Mario Giuffrè; Aurora Aleo; Teresa Fasciana; Francesca Di Bernardo; Tomaso Stampone; Anna Giammanco; Daniela Maria Palma; Caterina Mammina
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

8.  Exploring Dangerous Connections between Klebsiella pneumoniae Biofilms and Healthcare-Associated Infections.

Authors:  Maria Bandeira; Patricia Almeida Carvalho; Aida Duarte; Luisa Jordao
Journal:  Pathogens       Date:  2014-08-19

Review 9.  Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods.

Authors:  Chang-Ro Lee; Jung Hun Lee; Kwang Seung Park; Young Bae Kim; Byeong Chul Jeong; Sang Hee Lee
Journal:  Front Microbiol       Date:  2016-06-13       Impact factor: 5.640

10.  Whole genome sequencing for the molecular characterization of carbapenem-resistant Klebsiella pneumoniae strains isolated at the Italian ASST Fatebenefratelli Sacco Hospital, 2012-2014.

Authors:  Sara Giordana Rimoldi; Bernardina Gentile; Cristina Pagani; Annamaria Di Gregorio; Anna Anselmo; Anna Maria Palozzi; Antonella Fortunato; Valentina Pittiglio; Anna Lisa Ridolfo; Maria Rita Gismondo; Giuliano Rizzardini; Florigio Lista
Journal:  BMC Infect Dis       Date:  2017-10-10       Impact factor: 3.090

View more
  22 in total

1.  Detection of OXA-48 Gene in Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae from Urine Samples.

Authors:  Sushma Gurung; Sonali Kafle; Binod Dhungel; Nabaraj Adhikari; Upendra Thapa Shrestha; Bipin Adhikari; Megha Raj Banjara; Komal Raj Rijal; Prakash Ghimire
Journal:  Infect Drug Resist       Date:  2020-07-14       Impact factor: 4.003

2.  Whole Genome Sequencing of Peruvian Klebsiella pneumoniae Identifies Novel Plasmid Vectors Bearing Carbapenem Resistance Gene NDM-1.

Authors:  David Roach; Adam Waalkes; Jorge Abanto; Joseph Zunt; Carolina Cucho; Jaime Soria; Stephen J Salipante
Journal:  Open Forum Infect Dis       Date:  2020-07-02       Impact factor: 3.835

3.  Virulent and multidrug-resistant Klebsiella pneumoniae from clinical samples in Balochistan.

Authors:  Sareeen Fatima; Faiza Liaqat; Ali Akbar; Muhammad Sahfee; Abdul Samad; Muhammad Anwar; Shazia Iqbal; Shabir Ahmad Khan; Haleema Sadia; Gul Makai; Anila Bahadur; Wajeeha Naeem; Adnan Khan
Journal:  Int Wound J       Date:  2021-01-21       Impact factor: 3.315

4.  Evaluation of Modified Rapid Carbapenem Inactivation Method (mrCIM) Combined with Rapid EDTA-Modified Carbapenem Inactivation Method (reCIM) to Detect Carbapenemase and Distinguish Metallo-Carbapenemase in Enterobacteriaceae Within Four Hours.

Authors:  Qiang Wei; Jide Sun; Zhu Wang; Li Yan; Chuanming Zhang; Xiuyu Xu
Journal:  Infect Drug Resist       Date:  2020-06-23       Impact factor: 4.003

5.  A Retrospective Whole-Genome Sequencing Analysis of Carbapenem and Colistin-Resistant Klebsiella Pneumoniae Nosocomial Strains Isolated during an MDR Surveillance Program.

Authors:  Bernardina Gentile; Antonella Grottola; Gabriella Orlando; Giulia Fregni Serpini; Claudia Venturelli; Marianna Meschiari; Anna Anselmo; Silvia Fillo; Antonella Fortunato; Florigio Lista; Monica Pecorari; Cristina Mussini
Journal:  Antibiotics (Basel)       Date:  2020-05-12

6.  Hybrid Genome Assembly and Annotation of a Pandrug-Resistant Klebsiella pneumoniae Strain Using Nanopore and Illumina Sequencing.

Authors:  Zhi Ruan; Jianyong Wu; Hangfei Chen; Mohamed S Draz; Juan Xu; Fang He
Journal:  Infect Drug Resist       Date:  2020-01-21       Impact factor: 4.003

7.  Emerging high-risk ST101 and ST307 carbapenem-resistant Klebsiella pneumoniae clones from bloodstream infections in Southern Italy.

Authors:  Daniela Loconsole; Marisa Accogli; Anna Lisa De Robertis; Loredana Capozzi; Angelica Bianco; Anna Morea; Rosanna Mallamaci; Michele Quarto; Antonio Parisi; Maria Chironna
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-06-01       Impact factor: 3.944

8.  Genomic Analysis of Carbapenemase-Producing Extensively Drug-Resistant Klebsiella pneumoniae Isolates Reveals the Horizontal Spread of p18-43_01 Plasmid Encoding blaNDM-1 in South Africa.

Authors:  Yogandree Ramsamy; Koleka P Mlisana; Mushal Allam; Daniel G Amoako; Akebe L K Abia; Arshad Ismail; Ravesh Singh; Theroshnie Kisten; Khine Swe Han; David J Jackson Muckart; Timothy Hardcastle; Moosa Suleman; Sabiha Y Essack
Journal:  Microorganisms       Date:  2020-01-17

9.  Three Year Study of Infection Profile and Antimicrobial Resistance Pattern from Burn Patients in Southwest Iran.

Authors:  Amir Emami; Neda Pirbonyeh; Abdolkhalegh Keshavarzi; Fatemeh Javanmardi; Sedigheh Moradi Ghermezi; Tayyeb Ghadimi
Journal:  Infect Drug Resist       Date:  2020-05-20       Impact factor: 4.003

10.  Invasive Klebsiella pneumoniae Infections in Community-Settings and Healthcare Settings.

Authors:  Yue Qiu; Daojiong Lin; Yi Xu; Yibing Cheng; Fang Wang; Qingxiong Zhu; Chunhui Zhu; Chaomin Wan; Yu Zhu; Jianning Tong; Rui Li; Qionghua Zhou; Minxia Chen; Qingwen Shan; Zhiqiang Zhuo; Caihong Wang; Shiyong Zhao; Wen Song; Mei Zeng
Journal:  Infect Drug Resist       Date:  2021-07-12       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.